Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease ; volume:20 ; number:1 ; day:5 ; month:3 ; year:2020 ; pages:1 ; date:12.2020
BMC neurology ; 20, Heft 1 (5.3.2020), 1, 12.2020
- Creator
-
Ortner, Marion
Drost, René
Hedderich, Dennis
Goldhardt, Oliver
Müller-Sarnowski, Felix
Diehl-Schmid, Janine
Förstl, Hans
Yakushev, Igor
Grimmer, Timo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-020-01649-9
- URN
-
urn:nbn:de:101:1-2020052523551725503057
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ortner, Marion
- Drost, René
- Hedderich, Dennis
- Goldhardt, Oliver
- Müller-Sarnowski, Felix
- Diehl-Schmid, Janine
- Förstl, Hans
- Yakushev, Igor
- Grimmer, Timo
- SpringerLink (Online service)
Other Objects (12)
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
Darstellung visuokonstruktiver Verarbeitung bei der Alzheimer-Demenz mit 18F-FDG-PET
Darstellung visuokonstruktiver Verarbeitung bei der Alzheimer-Demenz mit 18F-FDG-PET
FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
FDG-PET AND PET/CT-Part I
FDG-PET in lymphoma
Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer’s disease and FDG-PET findings
Amyloid PET imaging: applications beyond Alzheimer’s disease
Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images
PET imaging of mGluR5 in Alzheimer’s disease
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
Darstellung visuokonstruktiver Verarbeitung bei der Alzheimer-Demenz mit 18F-FDG-PET
Darstellung visuokonstruktiver Verarbeitung bei der Alzheimer-Demenz mit 18F-FDG-PET
FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
FDG-PET AND PET/CT-Part I
FDG-PET in lymphoma
Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer’s disease and FDG-PET findings
Amyloid PET imaging: applications beyond Alzheimer’s disease
Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images
PET imaging of mGluR5 in Alzheimer’s disease
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
Darstellung visuokonstruktiver Verarbeitung bei der Alzheimer-Demenz mit 18F-FDG-PET
Darstellung visuokonstruktiver Verarbeitung bei der Alzheimer-Demenz mit 18F-FDG-PET
FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
FDG-PET AND PET/CT-Part I
FDG-PET in lymphoma
Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer’s disease and FDG-PET findings
Amyloid PET imaging: applications beyond Alzheimer’s disease
Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images